Cytochrome P450 (CYP) enzyme 2B1 metabolizes the anticancer prodrug cyclophosphamide (CPA) to 4-hydroxy-CPA, which decomposes to the cytotoxic metabolites acrolein and phosphoramide mustard. We have evaluated the bystander cytotoxicity of CPA in combination with CYP2B1 gene-directed enzyme prodrug therapy using a cell culture-based agarose overlay technique. This method mimics the tumor microenvironment by limiting the diffusion of metabolites and by reducing the oxygen concentration to levels similar to those found in solid tumors. Under these conditions, the CYP activity of CYP2B1-expressing tumor cells was decreased by 80% compared to standard aerobic conditions. Despite this decrease in metabolic activity, a potent bystander effect was observed, resulting in up to 90% killing by CPA of a tumor cell population comprised of only B20% CYP-expressing tumor cells. Similarly, transient transfection of a small fraction (B14%) of a human hepatoma Huh7 cell population with a CYP2B1 expression plasmid followed by short-term treatment with CPA (5 h) led to an eradication of 95% of the cells. No such bystander effect was observed without the agarose overlay. These findings suggest that the agarose overlay technique is very useful as an in vitro test system for investigation of the bystander effect of CYP/CPA and other enzyme/prodrug combinations under conditions that mimic the hypoxic conditions present in solid tumors in vivo.
Introduction
Tumor cell delivery of genes coding for prodrug activation enzymes is a promising approach for the treatment of solid tumors. A broad range of such enzyme-prodrug combinations have been extensively researched for their utility in cancer therapy leading to clinical trials. 1 These gene-directed enzyme prodrug therapies (GDEPT) aim to increase antitumor activity by conversion of an inactive prodrug into an active, cytotoxic metabolite after delivery of the therapeutic gene to the tumor using either viral or non-viral gene transfer methods. High concentrations of active, cytotoxic drugs may thus be generated within a tumor, which may ultimately allow for a reduction in drug dosage and an associated reduction in side effects associated with systemic exposure to toxic drug metabolites. 2 Cyclophosphamide (CPA) is an alkylating agent widely used in cancer therapy. Cyclophosphamide is activated in the liver in a reaction catalyzed by specific cytochrome P450 (CYP) enzymes (for review, see Roy and Waxman 3 ). The primary active metabolite, 4-OH-CPA, is transported from the liver to the tumor through the blood stream. Tumor cells infected with a viral vector encoding a CPAactivating CYP gene are highly sensitized to the cytotoxic actions of CPA, as are surrounding tumor cells, through their exposure to diffusible, cytotoxic metabolites produced by the CYP-expressing tumor cells. 4, 5 Thus, CYP gene transfer can increase antitumor activity by providing for the activation of CPA at the target site. 6 Drug diffusion and concentration effects within a tumor play an important role in the action of drugs, such as CPA, owing to the short half-life of its active metabolites, 7 especially within the context of a GDEPT strategy. In contrast to other GDEPT-based enzyme/ prodrug combinations, such as herpes simplex virus thymidine kinase/ganciclovir, 4-OH-CPA readily diffuses across cell membranes and is not dependent on direct cell-cell contact for bystander killing. Tumor cell uptake of CPA and 4-OH-CPA is facilitated by the low extracellular pH associated with tumors, which may increase intracellular accumulation of this weakly acidic drug and its metabolite by an ion trapping mechanism.
including CPA. In addition to the level of CYP gene expression, the extent of CPA activation is highly dependent on the availability of O 2 , which is a cosubstrate for all CYP-catalyzed monooxygenation reactions. Low oxygen pressure resulting from an insufficient blood supply is a hallmark of solid tumors. 10 Despite the limited oxygen supply, excellent antitumor activity was reported in mouse and rat models of GDEPT using CYP2B enzymes 1, 11 with some indications of efficacy reported in initial clinical trials after local delivery of a CYP gene. 12 In this study, we use an agarose overlay technique to study the effect of limited diffusion and reduced oxygen supply on the bystander cytotoxicity of CYP-activated CPA. Studies carried out with a tumor cell line that stably expresses CYP2B1 demonstrate that the bystander cytotoxicity of CYP-activated CPA can be substantially enhanced using this technique. Moreover, transient transfection of the CYP2B1 gene led to eradication of tumor cells subsequently treated with CPA.
Materials and methods
Reagents, chemicals and plasmids Agarose ultrapure, geneticin, cell culture medium and fetal bovine serum (FBS) were purchased from Invitrogen GmbH (Karlsruhe, Germany). XhoI restriction enzyme and Â 10 buffer D were obtained from Promega (Mannheim, Germany). Plasmids pCR3.1-CYP2B1 (rat CYP2B1 under the control of the cytomegalovirus (CMV) enhancer/promoter 5 ) and pEGFP-N1 (Clontech, Palo Alto, CA, USA) were produced and purified by ELIM Biopharmaceuticals (San Francisco, CA) with endotoxin levels o0.1 EU/50 mg DNA. pCMV-Luc plasmid was purified with the Qiagen Endo Free Giga kit (Qiagen, Hilden, Germany). Linear polyethylenimine (PEI) with an average molecular weight of 22 kDa (PEI22) was purchased from PolyPlus (Illkirch, France) and used at a 1 mg/ml working solution, neutralized with HCl. All other regents were purchased from Sigma-Aldrich (Munich, Germany).
Cell culture
Murine neuroblastoma Neuro2A cells (ATCC CCl-131), murine colon adenocarcinoma CT26 cells (ATCC CRL-2638) and the stable, CYP2B1-expressing cell clone X39 were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. The human hepatoma cell line Huh7 (JCRB 0403; Tokyo, Japan) was cultured in DMEM/HAM's F12 medium, supplemented with 10% FBS, all at 371C in 5% CO 2 and a humidified atmosphere.
Generation of a CYP2B1-expressing clone X39 Plasmid pCR3.1-CYP2B1 was linearized by digestion with XhoI, followed by agarose gel electrophoresis and Qiaprep s Spin MiniprepKit 250 (Qiagen) purification according to the manufacturer's instructions. CT26 cells were seeded and transfected in 24-well plates. The transfection complex of linearized pCR3.1-CYP2B1 plasmid with PEI was generated at an N/P ratio (nitrogen in PEI/phosphate in DNA) of 6 in HBS (HEPES-buffered saline: 20 mM HEPES pH 7.1, 150 mM NaCl) at a final DNA concentration of 20 mg/ml. 13 Forty-eight hours after transfection, cells were selected with 0.5 mg geneticin per ml culture medium. To obtain subclones, the surviving cells were re-seeded in a 96-well plate at 1 cell/well after 2 weeks of geneticin selection. Subclones were analyzed and characterized for CYP2B1 activity using pentoxyresorufin as substrate. Clone X39 gave the highest P450 activity and was used in all subsequent experiments.
Agarose overlay method Cells were seeded either in 24-well (Hoechst 33258 diffusion experiment) or 48-well plates (all other assays) 24 h before addition of the agarose overlay. Culture medium was removed and replaced with 345 ml medium (24-well plates) or 200 ml medium (48-well plates) containing 0.5% (w/v) agarose. The agarose-containing medium was obtained by stepwise dilution of complete medium with melted agarose (10% agarose in phosphate-buffered saline (PBS), w/v). Before applying the agarose-containing medium to the seeded cells, the medium was allowed to cool to 371C. After solidification of the agarose, 1040 ml (24-well plate) or 600 ml (48-well plate) of complete culture medium without agarose (7CPA) was added to the cells.
Pentoxyresorufin assay
A modified assay was used to assay CYP2B1 activity. 14 Cells were incubated in 48-well plates with 200 ml Optimem I medium containing 1.7 mM 7-pentoxyresorufin and 100 mM 3,3 0 -methylene-bis(4-hydroxycoumarin) ('substrate solution') for 20-120 min. Following incubation, the cells were subject to a freeze-thaw cycle to stop the enzymatic reaction. The supernatant was transferred to a 1.5 ml reaction tube, centrifuged at 15 000 g for 10 min and 150 ml of the clear liquid was assayed for fluorescence using a Cary Eclipse fluorimeter (Cary, Mulgrave, Australia) with excitation and emission wavelengths set to 562 and 585 nm, respectively. Measurements were performed in triplicate and enzyme activity was expressed as relative fluorescence units .
When measuring CYP activity under the agarose layer ( Figure 3b , ' þ gel'), 200 ml substrate solution was injected between the adherent cells and the agarose layer after solidification of the 200 ml agarose overlay. After incubation at 371C for 40 min, the agarose layer was removed and the resorufin content in the supernatant was quantified. In the '-gel' samples, 200 ml substrate solution was added to the cells under standard conditions, which were incubated for 40 min at 371C followed by resorufin content quantification. In the case of the 'gel removed' samples, cells were overlaid with 200 ml agarose for 1 h. Thereafter, the gel was removed, 200 ml substrate solution added to the cells and after incubation at 371C for 40 min resorufin was quantified in the supernatant. No significant amounts of resorufin were found in the agarose layer, indicating that the majority of resorufin is localized in the solution between the cells and the agarose overlay.
When performing the pentoxyresorufin assay in a hypoxia chamber, 100 000 X39 cells were seeded in a 3.5 cm culture dish. Twenty-four hours after seeding, the cells were incubated in the hypoxia chamber for 40 min with 500 ml of the substrate solution either under normoxia (21% O 2 ) or under various decreased O 2 concentrations, with O 2 replaced by a mixture of N 2 and CO 2 . Oxygen partial pressure was measured with a digital oxymeter (GMH 3690, Greisinger Electronic, Germany). Relative humidity and temperature (371C) were similar under all conditions.
DNA content assay
To assay for DNA content, the culture medium and the agarose layer were removed and cells were lysed with Millipore water followed by a freeze-thaw cycle. Cell lysis buffer (1 mM Tris-EDTA, pH 7.4, 200 mM NaCl) containing 0.2 ng/ml Hoechst 33258 was applied to each well followed by another freeze-thaw cycle. The DNA content was measured by quantifying fluorescence with a plate reader (Tecan, Gro¨dig, Austria) equipped with filters for excitation at 360 nm and emission at 465 nm. Results obtained with the DNA content assay correlate well with those of the 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide (MTT) assay (described below) under normoxic culture conditions, but not under longterm hypoxic conditions (e.g., under an agarose overlay), where the results of the MTT assay were artificially low, perhaps owing to adaptation mechanisms. 15 As the DNA content assay always correlates with cell numbers and, in the presence of oxygen, with the MTT assay as well (M Gu¨nther, unpublished observations), cytotoxicity assays with long-term agarose overlay were evaluated by the DNA content assay, whereas for short-term agarose overlay (transient transfection experiments, see below), the MTT assay was used.
3-(4,5-Dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide assay After removing the culture medium and, if applicable, the agarose layer, 300 ml of culture medium containing 0.25% MTT (w/v) was applied to each well after which the plates were incubated for 3 h at 371C. 3-(4,5-Dimethylthiazol-2-yl)2,5-diphenyltetrazolium bromide is converted to a colored, water-insoluble formazan salt by the metabolic activity of viable cells. The culture medium was then removed and the cells were frozen at À801C. After thawing the cells, 300 ml of dimethylsulfoxide was added to dissolve the insoluble formazan salt and absorbance at 590 nm was measured with a plate reader (Tecan, Gro¨dig, Austria). A reference absorbance at 630 nm was subtracted from the absorbance at 590 nm for each well.
Bystander cytotoxicity assay
The bystander effect of CYP-activated CPA was assayed by measuring the DNA content and the metabolic activity (MTT) of a cell population composed of different percentages of X39 cells mixed with either Neuro2A cells or CT26 cells, followed by CPA treatment. In total, 1500 cells per well were plated in 48-well plates. Twentyfour hours after seeding, the culture medium was removed and replaced by either 200 ml of fresh medium or 200 ml of medium containing 0.5% (w/w) agarose. Then, 600 ml of 0.66 mM CPA dissolved in culture medium was added to each well. Control cells were treated with 600 ml culture medium without CPA. The total volume was 800 ml with a final CPA concentration of 0.5 mM. Treated cells and controls were incubated for 5 days in a humidified atmosphere containing 5% CO 2 at 371C. DNA contents were then assayed.
Transgene expression analysis after transient transfection Huh7 cells were seeded 24 h before transient transfection in a 48-well plate. Cells were transfected with 100 ng pCR3.1-CYP2B1 or pCMV-EGFP-N1 using linear PEI (N/P 6 in HBS). Forty-eight hours after transfection, the cells were washed with PBS and harvested by trypsin treatment. For analysis of enhanced green fluoroscent protein (EGFP) expression, the cells were analyzed as described. 16 For analysis of CYP2B1 expression, cells were fixed with 2% paraformaldehyde in PBS, followed by permeabilization with 0.1% (w/v) Triton X-100 in PBS. Cells in 5% FBS in PBS were incubated with mouse monoclonal antirat CYP2B1 (Oxford Biomedical Research, Oxford, MI) or, as a control, with nonspecific mouse isotype control antibody. Alexa488-conjugated goat antimouse IgG (Molecular Probes) was used as a secondary antibody. Cells were analyzed on a Cyan MLE flow cytometer (DakoCytomation, Kopenhagen, Denmark). As an additional control, non-transfected cells were similarly stained and analyzed.
Bystander cytotoxicity assay after transient transfection Huh7 cells were seeded 24 h before transient transfection in a 48-well plate. Cells were transfected with 100 ng reporter gene plasmid (pCMV-Luciferase) or pCR3.1-CYP2B1 using linear PEI (N/P 6 in HBS). Forty-eight hours after transfection, the cells were treated for 5 h with 0.5 mM CPA with or without an agarose overlay. The culture medium and agarose were then removed and replaced with fresh medium. Cell viability was measured using the MTT assay after further culture for 3 days.
Results
Stable transfection of the murine colon carcinoma cell line CT26 with plasmid encoding CYP2B1 was carried out and a clone exhibiting high CYP activity (clone X39) was isolated. Cytochrome P450 activity was B300-fold higher in X39 cells compared to the parental CYP-deficient tumor cell line CT26, based on the CYP-catalyzed conversion of pentoxyresorufin to resorufin (Figure 1a ). The neuroblastoma cell line Neuro2A also exhibited very low CYP activity, whereas the human hepatoma cell line Huh7 had an endogenous CYP activity that was significantly higher, but still substantially lower than X39 cells (Figure 1a) .
Effects of hypoxia and limited diffusion on bystander effect of CYP M Günther et al Next, we evaluated the sensitivity of X39 and CT26 cells to the CYP prodrugs, CPA and ifosfamide (IFA), which are converted into their active metabolites by CYP2B1 (Figure 1b ). Cells were treated with increasing concentrations of each prodrug for 5 days, followed by measurement of the cell content of each culture using a DNA-based assay. 17 This assay is particularly suitable for evaluation of cytotoxicity under hypoxic conditions, as in the case of the agarose overlay technique described below (see Materials and methods). Highly efficient (90-95%) killing of X39 cells was achieved at 0.25-0.5 mM CPA, whereas no toxicity was seen under the same conditions with the CYP-deficient CT26 cells. Ifosfamide also induced a strong killing of X39 cells (85% toxicity at 0.5 mM IFA); however, some toxicity toward the CYPnegative CT26 cells was also apparent, especially at high drug concentrations. This difference is likely owing to differences in the intrinsic cytotoxicity of each prodrug. All further experiments were performed with CPA.
Diffusion of drugs is far more limited within a tumor in vivo than in tumor cells cultured in vitro. In addition, tumor cells are often subject to a hypoxic environment. These factors are both likely to impact the efficacy of CYP prodrug activation and bystander cytotoxicity. To better mimic the microenvironment within tumors, tumor cells seeded in tissue culture plates were covered with a thin layer of agarose dissolved in cell culture medium. Oxygen, nutrients and drugs can reach the cells by diffusion through the agarose layer. 18 We anticipated that the activated metabolites of CPA would form a concentration gradient in the vicinity of the drugactivating cells, similar to the situation in a solid tumor. To test this hypothesis, a small amount of the membranepermeable DNA stain Hoechst 33258 was added to the cells (Figure 2 ). When the stain was added to normal culture medium, the concentration was too low for detection of fluorescent cell nuclei. However, when a similar amount of Hoechst stain was injected in the agarose layer covering the cells, bright fluorescent nuclei were observed near the injection site. More distant cells were less fluorescent but still visibly stained. Thus, the agarose layer is likely to limit diffusion of low molecular weight drugs and their metabolites, thereby establishing a concentration gradient. Hoechst 33258 is a good model for CPA in terms of diffusion within a gel, as both drugs have a low molecular weight (M r (Hoechst 33258) ¼ 624 Da; M r (CPA) ¼ 250 Da) and both drugs are hydrophilic.
Our next goal was to determine if the agarose overlay imposes a hypoxic environment. We first investigated the extent to which CYP activity is oxygen-dependent in X39 cells (Figure 3 ). Cells were incubated with the CYP2B1 substrate pentoxyresorufin in a hypoxia chamber under defined ambient oxygen concentrations. The culture medium was assayed for enzymatic conversion of the substrate pentoxyresorufin to the fluorescent metabolite resorufin. Cytochrome P450 activity was directly dependent on the oxygen content, as indicated by the nearlinear correlation between O 2 concentration and CYP activity (Figure 3a) . Based on this calibration curve, CYP activity was reduced to B25% of the normoxic control level at 5% O 2 , and to 7% in the absence (o0.1%) of O 2 . In a separate experiment (Figure 3b ), X39 cells cultivated under standard conditions or under an agarose layer were assayed for CYP activity. The substrate, pentoxyresorufin, (1) was added directly to the culture medium ('Àgel'), (2) was carefully injected into the space between the cells and the agarose overlay (' þ gel') or (3) was added to cells cultured under agarose after the gel was removed ('gel removed'). The DNA content of each well was quantified to ensure that similar cell numbers were present in the individual wells. The CYP activity of cells grown under standard conditions was similar to that of cells cultured under agarose with removal of the agarose before substrate incubation. In contrast, CYP activity assayed in cells under the agarose layer was reduced to Effects of hypoxia and limited diffusion on bystander effect of CYP M Günther et al 12% compared to cells without the agarose (Figure 3b ), despite the presumed substrate concentrative effect of the agarose overlay. This CYP activity level corresponds to an oxygen concentration of about 1-2% based on the calibration curve shown in Figure 3a .
To rule out artifacts due to diffusion of resorufin into the agarose gel, a control experiment with resorufin injected under the agarose layer in the absence of cells was carried out. Approximately, 83% of the fluorescent dye was found in the solution under similar incubation conditions (data not shown). CYP2B1 protein levels were not influenced by the agarose overlay, as determined by antibody staining and flow cytometry analysis (data not shown). Hence, the agarose layer does not influence expression of CYP2B1. We conclude that the agarose overlay technique apparently mimics the tumor environment in terms of its restriction of oxygen supply available to the CYP-expressing tumor cells.
Co-culture experiments were carried out to determine the impact of the conditions imposed by the agarose overlay, that is, limited drug and metabolite diffusion and hypoxic conditions, on bystander antitumor activity. Different ratios of X39 and CT26 cells (Figure 4a The cells were treated with 0.5 mM CPA in standard cell culture medium (a and c) or after coating the cells with a layer of 0.5% agarose (b and d). After CPA treatment for 5 days, cell survival was measured using a DNA content assay. Under standard culture conditions, CT26 cells were quite resistant to the cytotoxic effects of CPA activated by X39 cells. Thus, 50% killing of the overall cell population was only achieved when the population was comprised of 75% CYP2B1-expressing (X39) cells (Figure 4a ). Neuro2A cells exhibited somewhat greater sensitivity to activated CPA, with 50% cell killing achieved in cocultures containing B60-65% X39 cells (Figure 4c) . By contrast, a remarkable bystander effect was achieved when agarose overlaid co-cultures were treated with CPA. In particular, CPA killed B80% of the Neuro2A þ X39 Effects of hypoxia and limited diffusion on bystander effect of CYP M Günther et al mixed cell population in cultures containing 25% CYPexpressing cells, and almost complete eradication of the Neuro2A þ X39 mixed cell population was achieved in cultures containing 50% CYP-expressing cells (Figure 4d ; also see CT26 cells in Figure 4b ). The CPA concentration achieved in tumor tissue in vivo can be quite low (o0.5 mM 19 ) owing to rapid clearance of the drug from the bloodstream (half-life o30 min 20 ). We therefore investigated if a bystander effect of activated CPA can also be obtained at low CPA concentrations ( Figure 5 ). CT26, Huh7 and X39 cells, and mixtures of X39 cells and either CT26 cells or Huh7 cells (25/75%) were treated for 5 days with 0.01-10 mM CPA in culture medium, with or without an agarose overlay. The CYPdeficient CT26 and Huh7 cells were quite resistant to CPA, both in the absence and presence of the agarose layer, and significant cell killing was only observed at CPA concentrations X3 mM (Figure 5a and b) . No beneficial effect of the agarose layer was observed in cultures comprised of X39 cells alone, as all the cells express CYP2B1 and generate 4-OH-CPA intracellularly, and thus no bystander effect is required for cell killing (Figure 5c ). In co-cultures of 25% X39 cells and 75% CT26 cells, the presence of an agarose overlay markedly increased CPA-induced cell killing (Figure 5d ). At 0.05 mM CPA, B40% cell killing was observed, both with and without the agarose overlay. As the X39 cells grow slightly faster than the parental cell line (data not shown), the 40% reduction in DNA content most probably reflects the killing of the 25% X39 cells seeded initially. A clear bystander effect was observed for the cells under the agarose layer at CPA concentrations between 0.1 and 1 mM, which corresponds to a pharmacologically relevant concentration range. In co-cultures of X39 cells with Huh7 hepatoma cells, 50% cell killing was achieved at very low concentrations of CPA (0.05 mM) and this effect was further enhanced by the agarose overlay ( Figure 5e ).
Next, we investigated the impact of the agarose overlay on bystander activity under conditions where CYP2B1 cDNA is delivered to the tumor cells by transient transfection, to mimic CYP gene delivery to tumor cells in vivo. Huh 7 cells were transfected with CYP2B1 cDNA using linear PEI, which resulted in B13% transfection efficiency, as shown by using EGFP as a reporter gene and confirmed by antibody staining for CYP2B1 (Figure 6a) . Using similar conditions, Huh7 cells were transfected with plasmid encoding CYP2B1, or luciferase, followed by treatment with 0.5 mM CPA (Figure 6b) . In cells transfected with CYP2B1 and overlayed with Effects of hypoxia and limited diffusion on bystander effect of CYP M Günther et al agarose, 490% of the cells were killed after only a 5-h CPA treatment, as judged in a cell growth inhibition assay scored 3 days later. The control cells, transfected with luciferase, showed only moderate toxicity.
Discussion
The diffusion of nutrients, drugs and metabolites within a solid tumor is limited. Moreover, most solid tumors are characterized by extended hypoxic regions and areas with an acidic microenvironment that are resistant to chemotherapy and radiotherapy. 10 Intratumoral activation of CYP prodrugs, such as the oxazaphosphorine CPA, is an oxygen-dependent reaction and can therefore be impacted by the lack of oxygen within a tumor. Nevertheless, CPA and IFA have been shown to be efficiently activated within tumors expressing CYP enzymes in the context of a GDEPT strategy, leading to enhanced cytotoxic responses. 21 Using viral vectors for gene delivery, only a fraction of the cells within a tumor can typically be transfected with a therapeutic gene. 6, 12 Non-viral gene delivery systems suffer from an even lower transfection efficiency. Nevertheless, they offer the possibility of safe and repeated administration of the transgene without the immunological complications associated with adenovirus and certain other viral vectors. In order for GDEPT to be therapeutically effective, a potent bystander effect is required so that a high fraction of tumor cells may be exposed to the tumor cell-generated cytotoxic metabolites. 22 Bystander studies are often carried out by mixing tumor cells transfected with a therapeutic gene with unmodified tumor cells. 22, 23 However, the specific therapeutic effect induced by a therapeutic gene in vivo may overlap with other effects that occur in vivo, including antiangiogenic effects, enzyme induction and immunogenic effects. On the other hand, results obtained in bystander experiments carried out in vitro may be non-physiological and reflect the unnatural environment of conventional cell culture. The present study was designed to address this issue by assessing the bystander activity of CYP-activated CPA in cell culture using an agarose overlay method that mimics the tumor microenvironment.
To evaluate the bystander activity of CYP/CPA, and potentially other enzyme/prodrug combinations, we devised a simple method that uses an agarose overlay technique to mimic in vitro two important features of the microenvironment of solid tumors, namely, limited diffusion of active drug metabolites and tumor hypoxia. The limitation in diffusion is especially important in the case of unstable, short-lived drug metabolites, such as those derived from CPA. Agarose has been described as a suitable material for simulation of diffusion within a solid tumor. 24 This effect was demonstrated by injecting the membrane-permeable DNA dye Hoechst 33258 into the agarose layer. The limited diffusion of this dye led to the formation of a concentration gradient and the staining of tumor cell nuclei in the immediate vicinity of the injection site ( Figure 2 ). The agarose overlay also imposed an apparent hypoxic environment on the cells, as shown by the 88% decrease in CYP metabolic activity of X39 tumor cells cultured under an agarose layer, which corresponds to the CYP activity at an ambient oxygen content of 2% (v/v). Despite the reduced activity, however, the CYPexpressing tumor cells cultured with the agarose overlay exhibited an enhanced bystander cytotoxic effect. The increased bystander activity was seen in experiments with co-cultures of CYP-expressing cells and CYP-deficient cells, and in experiments where the CYP cDNA was introduced by transient transfection.
Thus, with the agarose overlay, a population of 25% CYP-expressing Neuro2A cells killed 80% of the overall tumor cell population as compared to only 13% tumor cell killing in the absence of the overlay. Of note, X39 cells exerted greater bystander toxicity toward Huh7 hepatoma cells compared to CT26 cells. The enhanced sensitivity of the Huh7 cells toward CPA may in part be owing to the intrinsic CYP activity of Huh7 cells, which is B2% of that seen with the X39 clone (Figure 1 ). Short-term treatment (5 h) with 0.5 mM CPA should mimic the in vivo situation, where short exposures to CPA at peak levels of o1 mM can be found in tumor tissue, even after a highdose bolus of CPA. 25 In the transient transfection studies, where only a limited number of cells expressed CYP2B1 (13%, estimated based on an CYP2B1 antibody staining Effects of hypoxia and limited diffusion on bystander effect of CYP M Günther et al and EGFP as reporter gene; Figure 6a ), a clear CPAinduced killing effect was only observed for cells cultured under an agarose layer. In conclusion, the present studies highlight the utility of an agarose overlay method that mimics the hypoxic nature of the tumor microenvironment and the restricted diffusion of activated drug metabolites. In the case of CYP2B1-dependent CPA activation, the restricted diffusion of activated metabolites out from the tumor cell microenvironment is likely to prolong the exposure to elevated concentrations of active metabolites that play a crucial role in enhancing bystander cytotoxicity. Despite the fact that CYP activity, and therefore prodrug activation, is substantially reduced under the hypoxic conditions imposed by the agarose overlay, a strong bystander effect could nevertheless be observed as a consequence of the restricted diffusion of active metabolites. This bystander effect becomes even more important at low oxygen concentrations and under conditions where only a limited fraction of the tumor cells express the CYP gene, as is likely to be the case in any in vivo gene delivery situation. The agarose overlay method described here may also be suitable for studies of other prodrug activation enzymes and other conditions that involve responses to hypoxic conditions, limited diffusion of drugs and metabolites and paracrine effects.
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